Sequential identification of a degradable phosphate glass scaffold for skeletal muscle regeneration

Journal of Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 10, 2014, Pages 801-810

  Shah, Rishma ^a   Ready, Derren ^b   Knowles, Jonathan C ^a,c   Hunt, Nigel P ^a   Lewis, Mark P ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Dankook University   (South Korea)

^d LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Biomimetic material; Collagen; Craniofacial; Muscle; Phosphate glass; Scaffold

Indexed keywords

BACTERIA; BIOCOMPATIBILITY; BIOMIMETIC MATERIALS; BIOMIMETICS; DEFECTS; GENE EXPRESSION; GLASS; MUSCLE; SCAFFOLDS (BIOLOGY);

CRANIOFACIAL; GLASS COMPOSITIONS; GLASS SCAFFOLDS; MUSCLE REGENERATION; MYOFIBERS; PHOSPHATE GLASS; REGULATORY FACTORS; SKELETAL MUSCLE; TISSUES ENGINEERINGS; UP-REGULATION;

COLLAGEN;

MYOGENIC FACTOR; PHOSPHATE; PHOSPHATE GLASS; UNCLASSIFIED DRUG; CARDIAC MYOSIN; GLASS; MYH7 PROTEIN, HUMAN; MYH7 PROTEIN, RAT; MYOSIN HEAVY CHAIN;

ARTICLE; BACTERIAL GROWTH; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL COMPOSITION; CONTROLLED STUDY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CRANIOFACIAL MUSCLE DERIVED CELL; MUSCLE CELL; MUSCLE DISEASE; MUSCLE REGENERATION; MYH1 GENE; MYH2 GENE; MYH3 GENE; MYH6 GENE; MYH7 GENE; MYH8 GENE; NONHUMAN; SKELETAL MUSCLE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; UPREGULATION; ANIMAL; BIODEGRADABLE IMPLANT; BIOSYNTHESIS; CELL CULTURE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUSCLE FIBRIL; PATHOLOGY; RAT; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; ANIMALS; CARDIAC MYOSINS; CELLS, CULTURED; GLASS; HUMANS; MYOFIBRILS; MYOSIN HEAVY CHAINS; PHOSPHATES; RATS; REGENERATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84907889366     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1581     Document Type: Article

References (43)

1. Abou Neel EA, Ahmed I, Blaker JJ et al. 2005; Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres. Acta Biomater 1: 553-563.
2. Acarturk TO, Peel MM, Petrosko P et al. 1999; Control of attachment, morphology, and proliferation of skeletal myoblasts on silanized glass. J Biomed Mater Res 44: 355-370.
3. Ahmed I, Collins CA, Lewis MP et al. 2004; Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering. Biomaterials 25: 3223-3232.
4. Araujo MVF, Mendes VC, Chattopadhyay P et al. 2010; Low-temperature particulate calcium phosphates for bone regeneration. Clin Oral Implants Res 21: 632-641.
5. Arrecubieta C, Toba FA, von Bayern M et al. 2009; SdrF, a Staphylococcus epidermidis surface protein contributes to the initiation of ventricular assist device driveline-related infections. PLoS Pathog 5: 1-13.
6. Bach AD, Stern-Straeter J, Beier JP et al. 2003; Engineering of muscle tissue. Clin Plast Surg 30: 589-599.
7. Bader D, Masaki T, Fischman DA. 1982; Immunochemical analysis of myosin heavy-chain during avian myogenesis in vivo and in vitro. J Cell Biol 95: 763-770.
8. Bitar M, Salih V, Knowles JC et al. 2008; Iron-phosphate glass fiber scaffolds for the hard-soft interface regeneration: The effect of fiber diameter and flow culture condition on cell survival and differentiation. J Biomed Mater Res A 87A: 1017-1026.
9. Butler-Browne GS, Eriksson PO, Laurent C et al. 1988; Adult human masseter muscle-fibers express myosin isozyme characteristics of development. Muscle Nerve 11: 610-620.
10. Chou WG, Pogell BM. 1981; Mode of action of pamamycin in staphylococcus-aureus. Antimicrob Agents Chemother 20: 443-454.
11. Clark P, Coles D, Peckham M. 1997; Preferential adhesion to and survival on patterned laminin organizes myogenesis in vitro. Exp Cell Res 230: 275-283.
12. Cooper RN, Tajbakhsh S, Mouly V et al. 1999; In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci 112: 2895-2901.
13. Chomczynski P, Sacchi, N. 1987; Single-step method of RNA isolation by acid Guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162: 156-159.
14. Cronin EM, Thurmond FA, Bassel-Duby R et al. 2004; Protein-coated poly(L-lactic acid) fibers provide a substrate for differentiation of human skeletal muscle cells. J Biomed Mater Res A 69A: 373-381.
15. DiEdwardo CA, Petrosko P, Acarturk TO et al. 1999; Muscle tissue engineering. Clin Plast Surg 26: 647-656.
16. Fawcett DW, Bloom W, Raviola E. 1994; Muscular Tissue. In Textbook of Histology, Raviola E (eds). Chapman & Hall: London; 260-308.
17. Franks K, Salih V, Knowles JC et al. 2002; The effect of MgO on the solubility behavior and cell proliferation in a quaternary soluble phosphate based glass system. J Mater Sci Mater Med 13: 549-556.
18. Fuchs JR, Nasseri BA, Vacanti JP. 2001; Tissue engineering: A 21st century solution to surgical reconstruction. Ann Thorac Surg 72: 577-591.
19. Geipel U. 2009; Pathogenic organisms in hip joint infections. Int J Med Sci 6: 234-240.
20. Grounds MD. 1991; Towards understanding skeletal-muscle regeneration. Pathol Res Pract 187: 1-22.
21. Hasty P, Bradley A, Morris JH et al. 1993; Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364: 501-506.
22. Huang NF, Lee RJ, Li S. 2010; Engineering of aligned skeletal muscle by micropatterning. Am J Transl Res 2: 43-55.
23. Isenberg BC, Tsuda Y, Williams C et al. 2008; A thermoresponsive microtextured substrate for cell sheet engineering with defined structural organization. Biomaterials 29: 2565-2572.
24. Kamelger FS, Marksteiner R, Margreiter E et al. 2004; A comparative study of three different biomaterials in the engineering of skeletal muscle using a rat animal model. Biomaterials 25: 1649-1655.
25. Lam MT, Huang YC, Birla RK et al. 2009; Microfeature guided skeletal muscle tissue engineering for highly organized 3-dimensional free-standing constructs. Biomaterials 30: 1150-1155.
26. Langer R, Vacanti JP. 1993; Tissue engineering. Science 260: 920-926.
27. Molnar P, Wang WS, Natarajan A et al. 2007; Photolithographic patterning of C2C12 myotubes using vitronectin as growth substrate in serum-free medium. Biotechnol Prog 23: 265-268.
28. Neumann T, Hauschka SD, Sanders JE. 2003; Tissue engineering of skeletal muscle using polymer fiber arrays. Tissue Eng 9: 995-1003.
29. Okano T, Matsuda T. 1998; Tissue engineered skeletal muscle: Preparation of highly dense, highly oriented hybrid muscular tissues. Cell Transplant 7: 71-82.
30. O'Neill MC, Stockdale FE. 1972; Differentiation without cell-division in cultured skeletal-muscle. Dev Biol 29: 410-418.
31. Powell CA, Smiley BL, Mills J et al. 2002; Mechanical stimulation improves tissue-engineered human skeletal muscle. Am J Physiol Cell Physiol 283: C1557-C1565.
32. Salih V, Franks K, James M et al. 2000; Development of soluble glasses for biomedical use Part II: The biological response of human osteoblast cell lines to phosphate-based soluble glasses. J Mater Sci Mater Med 11: 615-620.
33. Sciote JJ, Kentish JC. 1996; Unloaded shortening velocities of rabbit masseter muscle fibres expressing skeletal or alpha-cardiac myosin heavy chains. J Physiol 492: 659-667.
34. Shah R, Sinanan ACM, Knowles JC et al. 2005; Craniofacial muscle engineering using a 3-dimensional phosphate glass fibre construct. Biomaterials 26: 1497-1505.
35. Stål P, Eriksson PO, Schiaffino S et al. 1994; Differences in myosin composition between human orofacial, masticatory and limb muscles - enzyme-studies, immunohisto-studies land biochemical-studies. J Muscle Res Cell Motil 15: 517-534.
36. Uo M, Mizuno M, Kuboki Y et al. 1998; Properties and cytotoxicity of water soluble Na2O-CaO-P2O5 glasses. Biomaterials 19: 2277-2284.
37. Vacanti JP, Langer R. 1999; Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354: SI32-S134.
38. Vandenburgh H, Del Tatto M, Shansky J et al. 1998; Attenuation of skeletal muscle wasting with recombinant human growth hormone secreted from a tissue-engineered bioartificial muscle. Hum Gene Ther 9: 2555-2564
39. Vandenburgh HH, Karlisch P, Farr L. 1988; Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell Dev Biol 24: 166-174.
40. Weintraub H, Dwarki VJ, Verma I et al. 1991; Muscle-specific transcriptional activation by myod. Genes Dev 5: 1377-1386.
41. Weiss A, Leinwand LA. 1996; The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol 12: 417-439.
42. Yablonka-Reuveni Z, Rivera AJ. 1994; Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult-rat fibers. Dev Biol 164: 588-603.
43. Yu XY, Day DE, Long GJ et al. 1997; Properties and structure of sodium-iron phosphate glasses. J Non-Cryst Solids 215: 21-31.